Dabur India Ltd Q3 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/y4bx9qiyssu3rzx3eev15qf6.pdf

Key Takeaways


Demand Environment

Mohit Malhotra: “When the pie remains the same, the growth is hard to get. That's what one is trying to do.”

Portfolio Performance

CategoryTrendCommentary
Oral Care▲ StrongGrew 9.1%; Red franchise and Meswak delivered double-digit growth; Gels toothpaste grew 50% YoY; Dabur Oral Care is now #2 brand in modern trade pan India.
Hair Oils▲ Gaining shareGrew 3.1%; both coconut and perfumed oils grew ahead of category, gaining 125 bps and 236 bps share respectively; overall Hair Oil share at ~18%, highest ever.
Home Care▲ MixedGrew 5%; Odonil grew double digits in volume; Odomos under pressure from cyclones and delayed winters but gained 574 bps share; Sanifresh grew double digits.
Skincare▲ SteadyGrew 5.6% driven by Gulabari franchise (9% growth); new formats contributed more than 20% to the Gulabari portfolio.
Healthcare▼ SoftFlat overall; Health Supplements (Chyawanprash, honey) hit by unfavorable weather; Digestives grew 4% on Hajmola; OTC and Ethicals (Honitus, Shilajit, Health juices) posted high double-digit growth.
Beverages▼ WeakJuices and Nectar impacted by muted festive demand and competitive intensity; Nectar, the 70% market share leader, was the most affected segment, concentrated in the 200 ml pack in metro cities.
Foods▲ StrongCulinary growing at 30%; Badshah domestic portfolio growing at 15%.
International▲ StrongGrew 18.9% in constant currency, with double-digit growth in Middle East, North Africa, Egypt, UK, US, and Bangladesh; currency devaluations in Egypt, Nigeria, and Bangladesh impacted translated growth.
Mohit Malhotra: “So, we are trying to come out with modern formats of Chyawanprash. like tablets, liquid, powder Chyawanprash, capsules of Chyawanprash, whole format extension. That is underway and that is doing well.”

Competitive Intensity & Pricing


Oral Care: The Standout Engine

Mohit Malhotra: “For the first time they have given accreditation to a non-fluoride-based toothpaste. So, now we can get into dentist endorsements also and as we continue the efforts of doctor advocacy, this will also get leveraged...”

McKinsey Strategic Review

Mohit Malhotra: “Anything which doesn't have a right to win they will be questioning and there will be a debate happening between management and them to retain or to size down or to reduce investments or what to do.”

Margins & Profitability

Mohit Malhotra: “Our attempt will be to go to around 20-21% levels. That's what we were aiming at.”

Guidance & Commitments

CommitmentSpecificsTimeline
Demand recoverySequential improvement in demand, backed by infrastructure investments, good harvest, and government budget initiativesNext few months
Q4 revenue growthMid-single digit topline growth; sequential improvement over Q3Q4 FY25
Q4 marginsMaintain current marginsQ4 FY25
Margin targetReach 20–21% levels via price increases and cost savingsNo date (aspirational)
FY26 margin intentMaintain margins but slightly improve; excess reinvested into advertisingFY26
Inflation mitigation~5% inflation mitigated by calibrated price increases and cost-saving initiativesOngoing
Oral Care packaging revampDabur Red packaging modernized for modern tradeComing fiscal year
Oral Care gap-fillingLaunches in sensitive, bleeding gums, and whitening segmentsNext season
Beverage recoveryThree-pronged strategy: communication revamp, consumer offer on nectar, new economical rangeUpcoming season
Chyawanprash all-weather positioningMonsoon campaign and memory-enhancing campaign to reduce seasonalityNo date
Lal Tail recoveryRate disturbance from consumer offer to be fully ironed out; new variant launch plannedNext quarter / upcoming season
McKinsey strategy exerciseThree-year vision covering all categories, with outcomes potentially including M&A, divestment, or exitsConclude by end of fiscal year
Siens range scale-upCurrently a proof-of-concept on e-commerce; scale-up plannedLater (no date)

Key Metrics

MetricQ3 FY25
Consolidated revenue growth3.1% in INR terms, 5.6% in constant currency terms
India business revenue growth1.7%, underpinned by volume growth of around 1.5%
International business growth18.9% in constant currency terms
Operating profit growth2.1% YoY
PAT growth1.8% YoY
HPC portfolio growth5.7%
Oral Care portfolio growth9.1%
Hair Oil portfolio growth3.1% YoY
Home Care growth5% YoY
Skincare portfolio growth5.6%
Healthcare portfolioFlat
Digestives growth4%
Foods: Culinary domestic portfolio growth30%
Foods: Badshah domestic portfolio growth15%
India business volume growth1.5%
Urban business growth0.6%
Rural business growth2%
Overall Hair Oil market share~18%, highest ever
Honey exit market share54%
Juices and Nectar category market share gain320 bps
Emerging channels share of India businessMore than 20%
Advertising spend as percentage of consumer care businessMore than 7%
Inflation YTD~3%; going forward expected ~5%
Namaste litigation costs₹75 cr in current year, down from ₹100 cr last year
International business translation loss₹81 cr